Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias.

Experimental models of Parkinson's disease have demonstrated abnormal synaptic plasticity in the corticostriatal system, possibly related to the development of levodopa-induced dyskinesias (LID). We tested the hypothesis that LID in Parkinson's disease is associated with aberrant plasticity in the human motor cortex (M1). We employed the paired associative stimulation (PAS) protocol, an experimental intervention involving transcranial magnetic stimulation (TMS) and median nerve stimulation capable of producing long-term potentiation (LTP) like changes in the sensorimotor system in humans. We studied the more affected side of 16 moderately affected patients with Parkinson's disease (9 dyskinetic, 7 non-dyskinetic) and the dominant side of 9 age-matched healthy controls. Motor-evoked potential (MEP) amplitudes and cortical silent period (CSP) duration were measured at baseline before PAS and for up to 60 min (T0, T30 and T60) after PAS in abductor pollicis brevis (APB) and abductor digiti minimi (ADM) muscles. PAS significantly increased MEP size in controls (+74.8% of baseline at T30) but not in patients off medication (T30: +0.07% of baseline in the non-dyskinetic, +27% in the dyskinetic group). Levodopa restored the potentiation of MEP amplitudes by PAS in the non-dyskinetic group (T30: +64.9% of baseline MEP) but not in the dyskinetic group (T30: -9.2% of baseline). PAS prolonged CSP duration in controls. There was a trend towards prolongation of CSP in the non-dyskinetic group off medications but not in the dyskinetic group. Levodopa did not restore CSP prolongation by PAS in the dyskinetic group. Our findings suggest that LTP-like plasticity is deficient in Parkinson's disease off medications and is restored by levodopa in non-dyskinetic but not in dyskinetic patients. Abnormal synaptic plasticity in the motor cortex may play a role in the development of LID.

[1]  T. Mima,et al.  Altered plasticity of the human motor cortex in Parkinson's disease , 2006, Annals of neurology.

[2]  Antonio Oliviero,et al.  Oscillatory pallidal local field potential activity inversely correlates with limb dyskinesias in Parkinson's disease , 2005, Experimental Neurology.

[3]  L. Cohen,et al.  Dopaminergic influences on formation of a motor memory , 2005, Annals of neurology.

[4]  E. Kunesch,et al.  Timing‐dependent plasticity in human primary somatosensory cortex , 2005, The Journal of physiology.

[5]  H. Braak,et al.  Cognitive status correlates with neuropathologic stage in Parkinson disease , 2005, Neurology.

[6]  G Baselli,et al.  Altered subthalamo-pallidal synchronisation in parkinsonian dyskinesias , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[7]  M. Bear,et al.  LTP and LTD An Embarrassment of Riches , 2004, Neuron.

[8]  T. Chase.  Striatal plasticity and extrapyramidal motor dysfunction. , 2004, Parkinsonism & related disorders.

[9]  D. Ruge,et al.  Learning Modifies Subsequent Induction of Long-Term Potentiation-Like and Long-Term Depression-Like Plasticity in Human Motor Cortex , 2004, The Journal of Neuroscience.

[10]  H. Siebner,et al.  Abnormal associative plasticity of the human motor cortex in writer's cramp. , 2003, Brain : a journal of neurology.

[11]  F. Crépel,et al.  Dopaminergic modulation of long-term synaptic plasticity in rat prefrontal neurons. , 2003, Cerebral cortex.

[12]  Gregory F. Molnar,et al.  Short and long latency afferent inhibition in Parkinson's disease. , 2003, Brain : a journal of neurology.

[13]  Robert Chen,et al.  An automated method to determine the transcranial magnetic stimulation-induced contralateral silent period , 2003, Clinical Neurophysiology.

[14]  Paul Greengard,et al.  Loss of bidirectional striatal synaptic plasticity in L-DOPA–induced dyskinesia , 2003, Nature Neuroscience.

[15]  L. Cohen,et al.  A temporally asymmetric Hebbian rule governing plasticity in the human motor cortex. , 2003, Journal of neurophysiology.

[16]  P. Brown.  Oscillatory nature of human basal ganglia activity: Relationship to the pathophysiology of Parkinson's disease , 2003, Movement disorders : official journal of the Movement Disorder Society.

[17]  L. Cohen,et al.  Mechanisms of enhancement of human motor cortex excitability induced by interventional paired associative stimulation , 2002, The Journal of physiology.

[18]  A. Nambu,et al.  Functional significance of the cortico–subthalamo–pallidal ‘hyperdirect’ pathway , 2002, Neuroscience Research.

[19]  J. Yelnik.  Functional anatomy of the basal ganglia , 2002, Movement disorders : official journal of the Movement Disorder Society.

[20]  G. Deuschl,et al.  Pathophysiology of Parkinson's disease: From clinical neurology to basic neuroscience and back , 2002, Movement disorders : official journal of the Movement Disorder Society.

[21]  M. Muenter,et al.  Frequency of levodopa‐related dyskinesias and motor fluctuations as estimated from the cumulative literature , 2001, Movement disorders : official journal of the Movement Disorder Society.

[22]  A. Lang,et al.  Long-term follow-up of unilateral pallidotomy in advanced Parkinson's disease. , 2000, The New England journal of medicine.

[23]  Chase Tn,et al.  Striatal mechanisms and pathogenesis of parkinsonian signs and motor complications. , 2000 .

[24]  J A Obeso,et al.  Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: problems with the current model. , 2000, Annals of neurology.

[25]  S Fahn,et al.  The spectrum of levodopa-induced dyskinesias. , 2000, Annals of neurology.

[26]  G Bernardi,et al.  Levodopa-induced dyskinesia: a pathological form of striatal synaptic plasticity? , 2000, Annals of neurology.

[27]  L. Cohen,et al.  Induction of plasticity in the human motor cortex by paired associative stimulation. , 2000, Brain : a journal of neurology.

[28]  T. Chase,et al.  Striatal mechanisms and pathogenesis of parkinsonian signs and motor complications. , 2000, Annals of neurology.

[29]  P. Calabresi,et al.  Unilateral dopamine denervation blocks corticostriatal LTP. , 1999, Journal of neurophysiology.

[30]  K J Werhahn,et al.  Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans , 1999, The Journal of physiology.

[31]  A. Lang,et al.  Posteroventral medial pallidotomy in advanced Parkinson's disease. , 1997, Advances in neurology.

[32]  J. Donoghue,et al.  Strengthening of horizontal cortical connections following skill learning , 1998, Nature Neuroscience.

[33]  C. Marsden,et al.  What do the basal ganglia do? , 1998, The Lancet.

[34]  L. Metman,et al.  Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease , 1998, Neurology.

[35]  M. Delong,et al.  Functional and pathophysiological models of the basal ganglia , 1996, Current Opinion in Neurobiology.

[36]  P. Calabresi,et al.  The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia , 1996, Trends in Neurosciences.

[37]  A. Parent,et al.  Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop , 1995, Brain Research Reviews.

[38]  L. Raymond,et al.  Glutamate receptor modulation by protein phosphorylation , 1994, Journal of Physiology-Paris.

[39]  T. Engber,et al.  NMDA receptor blockade reverses motor response alterations induced by levodopa. , 1994, Neuroreport.

[40]  R. Kötter.  Postsynaptic integration of glutamatergic and dopaminergic signals in the striatum , 1994, Progress in Neurobiology.

[41]  P. Rossini,et al.  Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. , 1994, Electroencephalography and clinical neurophysiology.

[42]  M. Bear,et al.  Synaptic plasticity: LTP and LTD , 1994, Current Opinion in Neurobiology.

[43]  N Accornero,et al.  Motor cortical inhibition and the dopaminergic system. Pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson's disease and drug-induced parkinsonism. , 1994, Brain : a journal of neurology.

[44]  Y. Agid,et al.  Levodopa‐induced dyskinesias in Parkinson's disease phenomenology and pathophysiology , 1994, Movement disorders : official journal of the Movement Disorder Society.

[45]  L. Raymond,et al.  Phosphorylation of amino acid neurotransmitter receptors in synaptic plasticity , 1993, Trends in Neurosciences.

[46]  P. Calabresi,et al.  Long-term synaptic depression in the striatum: physiological and pharmacological characterization , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[47]  B. Berger,et al.  Alterations of dopaminergic and noradrenergic innervations in motor cortex in parkinson's disease , 1991, Annals of neurology.

[48]  I. Vardi,et al.  [Writer's cramp]. , 1981, Harefuah.

[49]  J. Winn,et al.  Brain , 1878, The Lancet.

[50]  R. C. Oldfield.  The assessment and analysis of handedness: the Edinburgh inventory. , 1971, Neuropsychologia.